SCHEMBL9315699

SCHEMBL9315699

O=C1CC(c2cc3cc(C(F)(F)F)ccc3o2)CN1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.44
PIM2 Q9P1W9 1/20 0.44
MAOA P21397 1/20 0.42
MAOB P27338 2/20 0.37
ADAMTS4 O75173 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37
MMP9 P14780 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MMP14 P50281 1/20 0.37
ADAMTS5 Q9UNA0 1/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
HRH3 Q9Y5N1 3/20 0.35
PARP1 P09874 1/20 0.35
PARP10 Q53GL7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9202060 0.83 CA12 (0.40) ALDH1A1CYP1A2CYP2C19MTNR1APGR
SCHEMBL9315800 0.80 ALDH1A1 (0.43) MAOAMAOBALDH1A1CYP1A2CYP2C19
SCHEMBL9200232 0.80 MAOB (0.45) MAOBALDH1A1CYP1A2CYP2C19MTNR1A
SCHEMBL9201848 0.80 CYP2A6 (0.41) PIM1MAOAALDH1A1CYP1A2CYP2C19
SCHEMBL9195715 0.78 ACHE (0.55) MAOBALDH1A1CYP1A2CYP2C19MTNR1A
SCHEMBL9197524 0.77 TSHR (0.39) ALDH1A1CYP1A2CYP2C19MTNR1ACHRNB2
SCHEMBL9315026 0.77 ACHE (0.41) ALDH1A1CYP1A2CYP2C19PARP1MTNR1A
SCHEMBL9315695 0.73 MTNR1A (0.37) ALDH1A1CYP1A2CYP2C19MTNR1ACHRNB2
SCHEMBL9316757 0.73 PDE4A (0.38) ALDH1A1CYP1A2CYP2C19MTNR1APDE4A
SCHEMBL7085848 0.73 PIM1 (0.45) PIM1PIM2MAOAMAOBADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed